Cardiac syndrome X. the possible role of Na+-Li+-countertransport activity and other pathophysiological mechanisms in pathogenesis
- Authors: Oslopov VN1, Oslopova YV1, Borisov DV1
-
Affiliations:
- Kazan State Medical University, Kazan, Russia
- Issue: Vol 94, No 3 (2013)
- Pages: 355-361
- Section: Reviews
- URL: https://bakhtiniada.ru/kazanmedj/article/view/2184
- DOI: https://doi.org/10.17816/KMJ2184
- ID: 2184
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
V N Oslopov
Kazan State Medical University, Kazan, Russia
Y V Oslopova
Kazan State Medical University, Kazan, Russia
D V Borisov
Kazan State Medical University, Kazan, Russia
Email: dan-cer@inbox.ru
References
- Алексеева О.П., Долбин И.В., Федоренко А.А. Кардиальный синдром Х (особенности патогенеза и лечения). - Н. Новгород: Изд-во НГМА, 2007. - 120 с.
- Аронов Д.М., Лупанов В.П. Атеросклероз и коронарная болезнь сердца. - М.: Триада-Х, 2009. - 248 с.
- Калягин А.Н. Кардиалгический Х-синдром // Сибир. мед. ж. - 2001. - Т. 25, №2. - С. 9-14.
- Маев И.В., Юренев Г.Л., Бурков С.Г. и др. Внепищеводные проявления гастроэзофагеальной рефлюксной болезни // Тер. арх. - 2007. - №3. - С. 57-66.
- Международная Федерация Диабета (IDF): консенсус по критериям метаболического синдрома // Ожирен. и метабол. - 2005. - №3. - С. 47-50.
- Ослопов В.Н. Артериальная гипертензия и клеточная мембрана. - Казань: МеДДок, 2012. - 453 с.
- Постнов Ю.В., Орлов С.Н. Первичная артериальная гипертония как патология клеточных мембран. - М.: Медицина, 1987. - 190 с.
- Руда М.М., Парфёнова Е.В., Карпов Ю.А. Предшественники эндотелиальных клеток: роль в восстановлении функции эндотелия и перспективы терапевтического применения // Кардиология. - 2008. - №1. - С. 66-74.
- Anderson J.L., Adams C.D., Antman E.M. et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines // Circulation. - 2007. - Vol. 116, N 7. - P. 148-304.
- Bonetti P.O., Lerman L.O., Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk // Arterioscler. Thromb. Vasc. Biol. - 2003. - Vol. 23, N 2. - P. 168-175.
- Botker H.E., Moller N., Ovesen P. et al. Insulin resistance in microvascular angina (syndrome X) // Lancet. - 1993. - Vol. 342. - P. 136-140.
- Buchthal S.D., den Hollander J.A., Merz C.N. et al. Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms // N. Engl. J. Med. - 2000. - Vol. 342. - P. 829-835.
- Bugiardini R., Bairey Merz C.N. Angina with «normal» coronary arteries: a changing philosophy// JAMA. - 2005. - Vol. 293, N 4. - Р. 477-484.
- Canessa M., Adragna N., Solomon H.S. et al. Increased sodium-lithium countertransport in red cells of patients with essential hypertension // N. Engl. J. Med. - 1980. - Vol. 302. - P. 772-776.
- Cannon R.O., Camici P.G., Epstein S.E. Pathophysiological dilemma of syndrome X // Circulation. - 1992. - Vol. 85. - P. 883-892.
- Cannon R.O., Quyyumi A.A., Mincemoyer R. et al. Imipramine in patients with chest pain despite normal coronary angiograms // New Eng. J. Med. - 1994. - Vol. 330, N 20. - P. 1411-1417.
- Cay S., Tahir Durmaz T. Cardiac syndrome X: is it a treatable disease? // Int. J. Cardiol. - 2011. - Vol. 147. - P. 283-345.
- Chaitman B.R. Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions // Circulation. - 2006. - Vol. 113, N 20. - P. 2462-2472.
- Chauhan A., Mullins P.A., Thuraisingham S.I. et al. Effect of transcutaneous electrical nerve stimulation on coronary blood flow // Circulation. - 1994. - Vol. 89, N 2. - P. 694-702.
- Chen J.W., Lee W.L., Hsu N.W. et al. Effects of short-term treatment of nicorandil on exercise-induced myocardial ischemia and abnormal cardiac autonomic activity in microvascular angina // Am. J. Cardiol. - 1997. - Vol. 80, N 1. - P. 32-38.
- Cunningham C., Brown S., Kaski J.C. Effects of transcendental meditation on symptoms and electrocardiographic changes in patients with cardiac syndrome X // Am. J. Cardiol. - 2000. - Vol. 85, N 5. - P. 653-655.
- Di Monaco A., Bruno I., Sestito A. et al. Cardiac adrenergic nerve function and microvascular dysfunction in patients with cardiac syndrome X // Heart. - 2009. - Vol. 95, N 7. - P. 550-554.
- Dzavik V., Cotter G., Reynolds H.R. et al. Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging study // Eur. Heart J. - 2007. - Vol. 28, N 9. - P. 1109-1116.
- Egashira K., Inou T., Hirooka Y. et al. Evidence of impaired endothelium - dependent coronary vasodilation in patients with angina pectoris and normal coronary angiograms // N. Engl. J. Med. - 1993. - Vol. 328. - P. 1659-1664.
- Eriksson B.E., Tyni-Lennè R., Svedenhag J. et al. Physical training in syndrome X: physical training counteracts deconditioning and pain in syndrome X // J. Am. Coll. Cardiol. - 2000. - Vol. 36, N 5. - P. 1619-1625.
- Eugene B. Microvascular dysfunction in patients with cardiac syndrome X // Heart. - 2009. - Vol. 95. - P. 521.
- Galassi A.R., Crea F., Araujo L.I. et al. Comparison of myocardial blood flow in syndrome X and one vessel coronary artery disease // Am. J. Cardiol. - 1993. - Vol. 72. - P. 134-142.
- Gaspardone A., Ferri C., Crea F. et al. Enhanced activity of sodium-lithium countertransport in patients with cardiac syndrome X: a potential link between cardiac and metabolic syndrome X // J. Am. Coll. Cardiol. - 1998. - Vol. 32. - P. 2031-2034.
- Gupte S.A. Targeting the pentose phosphate pathway in syndrome X-related cardiovascular complications // Drug Dev. Res. - 2010. - Vol. 71. - P. 161-167.
- Hinoi T., Tomohiro Y., Kajiwara S. et al. Telmisartan, an angiotensin II type 1 receptor blocker, improves coronary microcirculation and insulin resistance among essential hypertensive patients without left ventricular hypertrophy // Hypertens. Res. - 2008. - Vol. 31, N 4. - P. 615-622.
- Kaski J.C., Rosano G.M., Collins P. et al. Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study // J. Am. Coll. Cardiol. - 1995. - Vol. 25, N 4. - P. 807-814.
- Kayaalti F., Kalay N., Basar E. et al. Effects of nebivolol therapy on endothelial functions in cardiac syndrome X // Heart Vessels. - 2010. - Vol. 25. - P. 92-96.
- Kayikcioglu M., Payzin S., Yavuzgil O. Benefits of statin treatment in cardiac syndrome X // Eur. Heart. J. - 2003. - Vol. 24. - P. 1999-2005.
- Kheradmand F., Rasmi Y., Nemati M., Mohammadzad M.H. AB0-Rh blood groups distribution in cardiac syndrome X patients // J. Cardiovasc. Dis. Res. - 2012. - Vol. 3, N 3. - P. 197-199.
- Lanza G.A., Giordano A.G., Pristipino C. et al. Abnormal cardiac adrenergic nerve function in patients with syndrome X detected by [123I]metaiodobenzylguanidine myocardial scintigraphy // Circulation. - 1997. - Vol. 96. - P. 821-826.
- Lanza G.A. Abnormal cardiac nerve function in syndrome X // Herz. - 1999. - Vol. 24. - P. 97-106.
- Lanza G.A., Colonna G., Pasceri V., Maseri A. Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X // Am. J. Cardiol. - 1999. - Vol. 84, N 7. - P. 854-856.
- Lanza G.A., Sestito A., Cammarota G. et al. Assessment of systemic inflammation and infective pathogen burden in patients with cardiac syndrome X // Am. J. Cardiol. - 2004. - Vol. 94. - P. 40-44.
- Lanza G.A., Sestito A., Sgueglia G.A. et al. Effect of spinal cord stimulation on spontaneous and stress-induced angina and «ischemia-like» ST-segment depression in patients with cardiac syndrome X // Eur. Heart J. - 2005. - Vol. 26, N 10. - P. 983-989.
- Lanza G.A. Cardiac syndrome X: a critical overview and future perspectives // Heart. - 2007. - Vol. 93, N 2. - P. 159-166.
- Lanza G.A., Crea F. Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management // Circulation. - 2010. - Vol. 121, N 21. - P. 2317-2325.
- Maseri A., Crea F., Kaski J.C. et al. Mechanisms of angina pectoris in syndrome X // J. Am. Coll. Cardiol. - 1991. - Vol. 17. - P. 499-506.
- Mehta P.K., Goykhman P., Thomson L.E. et al. Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease // JACC. Cardiovasc. Imag. - 2011. - Vol. 4. - P. 514-522.
- Palloshi A., Fragasso G., Piatti P. et al. Effect of oral L-arginine on blood pressure and symptoms and endothelial function in patients with systemic hypertension, positive exercise tests, and normal coronary arteries // Am. J. Cardiol. - 2004. - Vol. 93, N 7. - P. 933-935.
- Panting J.R., Gatehouse P.D., Yang G.Z. et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging // N. Engl. J. Med. - 2002. - Vol. 346. - P. 1948-1953.
- Rosano G.M., Collins P., Kaski J.C. et al. Syndrome X in women is associated with oestrogen deficiency // Eur. Heart J. - 1995. - Vol. 16. - P. 610-614.
- Sattar N. Insulin resistance and the metabolic syndrome as predictors of cardiovascular risk: where are we now? // Minerva Endocrinol. - 2005. - Vol. 30, N 3. - P. 121-138.
- Tiefenbacher C.P., Friedrich S., Bleeke T. et al. ACE inhibitors and statins acutely improve endothelial dysfunction of human coronary arterioles // Am. J. Physiol. Heart Circ. Physiol. - 2004. - Vol. 286, N 4. - P. 1425-1432.
- Tweddel A.C., Martin W., Hutton I. Thallium scan in syndrome X // Br. Heart J. - 1992. - Vol. 68. - P. 48-50.
- Vicari R.M., Chaitman B., Keefe D. et al. Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial // J. Am. Coll. Cardiol. - 2005. - Vol. 46, N 10. - P. 1803-1811.
Supplementary files
